| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Viehbacher Christopher | President and CEO, Director | BIOGEN INC., 225 BINNEY, CAMBRIDGE | /s/ Wendell Taylor, attorney-in-fact for Christopher A. Viehbacher | 10 Feb 2026 | 0001774478 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIIB | Common Stock | Options Exercise | $0 | +9,008 | +55% | $0.000000 | 25,451 | 06 Feb 2026 | Direct | |
| transaction | BIIB | Common Stock | Tax liability | $876,340 | -4,356 | -17% | $201.18 | 21,095 | 06 Feb 2026 | Direct | |
| transaction | BIIB | Common Stock | Options Exercise | $0 | +15,453 | +73% | $0.000000 | 36,548 | 06 Feb 2026 | Direct | |
| transaction | BIIB | Common Stock | Tax liability | $1,332,616 | -6,624 | -18% | $201.18 | 29,924 | 06 Feb 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIIB | Restricted Stock Unit | Options Exercise | $0 | -9,008 | -50% | $0.000000 | 9,009 | 06 Feb 2026 | Common Stock | 9,008 | $0.000000 | Direct | F1 |
| transaction | BIIB | Restricted Stock Unit | Options Exercise | $0 | -15,453 | -33% | $0.000000 | 30,907 | 06 Feb 2026 | Common Stock | 15,453 | $0.000000 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. |
| F2 | The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025. |